Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bode

Showing results (451-460 of 548) with videos related to

Pageof 55
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 15, 2000
Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injuryJ Ruef, S Q Liu, C Bode, et al.
The Journal of Biological Chemistry|January 15, 1989
Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activatorC Bode, M S Runge, E E Branscomb, et al.
Circulation|June 1, 1990
Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activatorC Bode, M S Runge, S Schönermark, et al.
Annals of Hematology|January 1, 1996
Restenosis following percutaneous revascularization--the potential role of thrombin and the thrombin receptorG A Stouffer, J F Schmedtje, D Gulba, et al.
Anesthesiology|February 1, 1997
Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigsA Gries, B W Böttiger, J Dörsam, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 13, 2001
Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasoundA Hansen, C Hehrlein, S Hardt, et al.
Pulmonary Pharmacology & Therapeutics|August 10, 2000
Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosisD C Bode, E D Pagani, W R Cumiskey, et al.
Journal of Neurochemistry|February 1, 1988
Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activityJ D McDonald, R G Cotton, I Jennings, et al.
Ultrasound in Medicine & Biology|October 13, 2001
Improved 3-D-echocardiographic endocardial border delineation using the contrast agent FS069 (Optison) transesophageal studies in a porcine modelM Handke, D M Schäfer, G Heinrichs, et al.
Zeitschrift Fur Kardiologie|April 1, 1990
[Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)]D C Gulba, C Bode, J Topp, et al.
Pageof 55

Showing results (451-460 of 548) with videos related to

Sort By:
Pageof 55
Arteriosclerosis, Thrombosis, and Vascular Biology|July 15, 2000
Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injuryJ Ruef, S Q Liu, C Bode, et al.
The Journal of Biological Chemistry|January 15, 1989
Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activatorC Bode, M S Runge, E E Branscomb, et al.
Circulation|June 1, 1990
Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activatorC Bode, M S Runge, S Schönermark, et al.
Annals of Hematology|January 1, 1996
Restenosis following percutaneous revascularization--the potential role of thrombin and the thrombin receptorG A Stouffer, J F Schmedtje, D Gulba, et al.
Anesthesiology|February 1, 1997
Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigsA Gries, B W Böttiger, J Dörsam, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 13, 2001
Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasoundA Hansen, C Hehrlein, S Hardt, et al.
Pulmonary Pharmacology & Therapeutics|August 10, 2000
Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosisD C Bode, E D Pagani, W R Cumiskey, et al.
Journal of Neurochemistry|February 1, 1988
Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activityJ D McDonald, R G Cotton, I Jennings, et al.
Ultrasound in Medicine & Biology|October 13, 2001
Improved 3-D-echocardiographic endocardial border delineation using the contrast agent FS069 (Optison) transesophageal studies in a porcine modelM Handke, D M Schäfer, G Heinrichs, et al.
Zeitschrift Fur Kardiologie|April 1, 1990
[Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)]D C Gulba, C Bode, J Topp, et al.
Pageof 55